Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Published in
Biology of Blood & Marrow Transplantation, August 2019
Pharmacology, Toxicology and Pharmaceutical Science
6
3%
Other
15
8%
Unknown
85
45%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2025.
All research outputs
#853,344
of 34,575,175 outputs
Outputs from Biology of Blood & Marrow Transplantation
#31
of 3,759 outputs
Outputs of similar age
#13,840
of 380,917 outputs
Outputs of similar age from Biology of Blood & Marrow Transplantation
#2
of 80 outputs
Altmetric has tracked 34,575,175 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,759 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.
